Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Little is known about the effectiveness of pharmacological interventions on autism spectrum disorder (ASD). This is a systematic review of the randomized controlled trials (RCTs) of oxytocin interventions in autism, made from January 1990 to September 2013. METHOD: A search of computerized databases was supplemented by manual search in the bibliographies of key publications. The methodological quality of the studies included in the review was evaluated independently by two researchers, according to a set of formal criteria. Discrepancies in scoring were resolved through discussion. RESULTS: The review yielded seven RCTs, including 101 subjects with ASD (males=95) and 8 males with Fragile X syndrome. The main categories of target symptoms tested in the studies were repetitive behaviors, eye gaze, and emotion recognition. The studies had a medium to high risk of bias. Most studies had small samples (median=15). All the studies but one reported statistically significant between-group differences on at least one outcome variable. Most findings were characterized by medium effect size. Only one study had evidence that the improvement in emotion recognition was maintained after 6 weeks of treatment with intranasal oxytocin. Overall, oxytocin was well tolerated and side effects, when present, were generally rated as mild; however, restlessness, increased irritability, and increased energy occurred more often under oxytocin. CONCLUSIONS: RCTs of oxytocin interventions in autism yielded potentially promising findings in measures of emotion recognition and eye gaze, which are impaired early in the course of the ASD condition and might disrupt social skills learning in developing children. There is a need for larger, more methodologically rigorous RCTs in this area. Future studies should be better powered to estimate outcomes with medium to low effect size, and should try to enroll female participants, who were rarely considered in previous studies. Risk of bias should be minimized. Human long-term administration studies are necessary before clinical recommendations can be made.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712 · cited 2×
“Participants were tested every 2 weeks on the Clinical Global Impressions (CGI) (Guy 1976), and received additional testing on the Yale Brown Obsessive Compulsive Scale (YBOCS) – Compulsion Subscale (Goodman et al. 1989), the Repetitive Behavior Scale – Revised (Bodfish et al. 2000), and the Social Responsiveness Scale…”
Skevington, S. M., Lotfy, M., & O'Connell, K. A. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018486.91360.00 · Cited by 4,686 · cited 2×
“At baseline and after the 6 weeks of treatment, participants were also tested on the Reading the Mind in the Eyes (Baron-Cohen et al. 2001), the Diagnostic Analysis of Nonverbal Accuracy (DANVA) (Baum and Nowicki 1989), and on a measure of quality of life, the World Health Organization Quality of Life Questionnaire (W…”
Baron‐Cohen, S., Wheelwright, S., Hill, J., Raste, Y., & Plumb, I. (2001) · Journal of Child Psychology and Psychiatry · doi:10.1111/1469-7610.00715 · Cited by 4,555 · cited 5×
“At baseline and after the 6 weeks of treatment, participants were also tested on the Reading the Mind in the Eyes (Baron-Cohen et al. 2001), the Diagnostic Analysis of Nonverbal Accuracy (DANVA) (Baum and Nowicki 1989), and on a measure of quality of life, the World Health Organization Quality of Life Questionnaire (W…”
InfluentialOxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690 · cited 3×
“…2007; Lerer et al. 2008; Liu et al. 2010; Li et al. 2012), and the demonstration that oxytocin administration can influence social behavior in humans (Kosfeld et al. 2005; Domes et al. 2007b; Guastella et al. 2008; Declerck et al. 2010), prompted the investigation of the effectiveness of oxytocin…”
Publication bias in clinical research
Easterbrook, P. J., Gopalan, R., Berlin, J. A., & Matthews, D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90201-y · Cited by 3,109 · cited 1×
“Some of the reported findings could be chance findings that favored the publication of the study because of the well-known prejudice in favor of positive results (Rosenthal 1979; Easterbrook et al. 1991).”
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538 · cited 2×
“…to the description of the procedures that prevent study participants, caregivers, or outcome assessors from knowing which intervention was received (Wood et al. 2008); ‘‘incomplete outcome data’’ refers to data missing because of attrition or exclusion from the analysis; ‘‘se-lective outcome…”
Die „Autistischen Psychopathen” im Kindesalter
Asperger, H. (1944) · Archiv für Psychiatrie und Nervenkrankheiten · doi:10.1007/bf01837709 · Cited by 2,163 · cited 1×
“A utism spectrum disorder (ASD) includes a set of conditions characterized by abnormalities in the domains of communication and socialization, and by a restricted and repetitive pattern of interests and activities (Kanner 1943; Asperger 1944; American Psychiatric Association 2011).”
Cited by
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
“Intranasal OT has gained momentum as a potential treatment for ASD but with similarly promising but inconsistent results thus far (Gordon et al., 2013, Aoki et al., 2014, Preti et al., 2014, Aoki et al., 2015, Auyeung et al., 2015, Guastella et al., 2015).”
ResultCotter, J., Granger, K., Backx, R., Hobbs, M., Looi, C. Y., & Barnett, J. H. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.11.014 · Cited by 369
“Despite some promising trials conducted in patients with psychotic, affective and autism spectrum disorders (Mercedes PerezRodriguez et al., 2015; Preti et al., 2014), its benefits appear inconsistent across studies and methodologically problematic (Bradley and Woolley, 2017; Leppanen et al., 2017).”
Granat, A., Gadassi, R., Gilboa-Schechtman, E., & Feldman, R. (2017) · Emotion · doi:10.1037/emo0000204 · Cited by 256
Pharmacological therapies for autism spectrum disorder: a review.
(2015) · PubMed Central · Cited by 150
Intranasal oxytocin, social cognition and neurodevelopmental disorders: A meta-analysis
Keech, B., Crowe, S., & Hocking, D. R. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.09.022 · Cited by 145
“For example, Ooi et al. (2017) meta-analyzed RCT’s examining the effect of intranasal and intravenous OT administration on social cognition in ASD.”
BackgroundResultInfluentialCore Symptoms of Autism Improved After Vitamin D Supplementation
Jia, F., Wang, B., Shan, L., Xu, Z., Staal, W. G., & Du, L. (2015) · Pediatrics · doi:10.1542/peds.2014-2121 · Cited by 145
Oxytocin and social functioning
Jones, C., Barrera, I., Brothers, S., Ring, R., & Wahlestedt, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/cjones · Cited by 132
Empathy in autism Spectrum disorder
Harmsen, I. E. (2019) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-019-04087-w · Cited by 129
Epigenetics of Autism Spectrum Disorder
Siu, M. T., & Weksberg, R. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-53889-1_4 · Cited by 121
Oxytocin and Autism Spectrum Disorders
Yamasue, H., & Domes, G. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_24 · Cited by 109
Munesue, T., Nakamura, H., Kikuchi, M., Miura, Y., Takeuchi, N., Anme, T., Nanba, E., Adachi, K., Tsubouchi, K., Sai, Y., et al. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00002 · Cited by 84
Busnelli, M., Kleinau, G., Muttenthaler, M., Stoev, S., Manning, M., Bibic, L., Howell, L. A., McCormick, P. J., Di Lascio, S., Braida, D., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00564 · Cited by 67
Oxytocin: Parallel Processing in the Social Brain?
Dölen, G. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12284 · Cited by 65
Yamasue, H. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12364 · Cited by 58
Region Specific Up-Regulation of Oxytocin Receptors in the Opioid Oprm1−/− Mouse Model of Autism
Gigliucci, V., Leonzino, M., Busnelli, M., Luchetti, A., Palladino, V. S., D’Amato, F. R., & Chini, B. (2014) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00091 · Cited by 56
The Potential of Nasal Oxytocin Administration for Remediation of Autism Spectrum Disorders
Okamoto, Y., Ishitobi, M., Wada, Y., & Kosaka, H. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666160413120845 · Cited by 33
“They proposed that these four studies have a higher risk of selection bias, and also did not reject the possibility of an existing publication bias [9].”
BackgroundHelping behavior in prairie voles: a model of empathy and the importance of oxytocin
Kitano, K., Yamagishi, A., Horie, K., Nishimori, K., & Sato, N. (2022) · iScience · doi:10.1016/j.isci.2022.103991 · Cited by 31
Boggio, P. S., Asthana, M. K., Costa, T. L., Valasek, C. A., & Osório, A. A. C. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00294 · Cited by 27
Preckel, K., Kanske, P., Singer, T., Paulus, F. M., & Krach, S. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-1036-x · Cited by 25
“A recent meta-analysis, which included randomized clinical trials from January 1990 to September 2013 showed promising effects of OXT interventions on autistic traits, especially regarding emotion recognition and eye-gaze behavior [16].”
MethodLeithead, A. B., Tasker, J. G., & Harony‐Nicolas, H. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13061 · Cited by 26
New therapeutic options for autism spectrum disorder: experimental evidences
Peñagarikano, O. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.301 · Cited by 24
Intranasal oxytocin enhances socially-reinforced learning in rhesus monkeys
Parr, L. A. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00278 · Cited by 23
Paradoxical Effects of Intranasal Oxytocin on Trust in Inpatient and Community Adolescents
Venta, A., Ha, C., Vanwoerden, S., Newlin, E., Strathearn, L., & Sharp, C. (2019) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1399401 · Cited by 15
Metadata
- Authors
- Preti, A., Melis, M., Siddi, S., Vellante, M., Doneddu, G., & Fadda, R.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-03
- Volume
- 24
- Issue
- 2
- Pages
- 54-68
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2324078106
- Cited by
- 114
- References
- 95
- FWCI
- 1.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.